Luoxin Aurovitas Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUOXIN AUROVITAS, and what generic and branded alternatives to LUOXIN AUROVITAS drugs are available?
LUOXIN AUROVITAS has seven approved drugs.
Summary for Luoxin Aurovitas
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 7 |
Drugs and US Patents for Luoxin Aurovitas
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Luoxin Aurovitas | TOBRAMYCIN | tobramycin | SOLUTION;INHALATION | 210871-001 | Jan 22, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Luoxin Aurovitas | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 207625-003 | Dec 30, 2016 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Luoxin Aurovitas | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 207628-001 | Jan 31, 2017 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Luoxin Aurovitas | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 207625-002 | Dec 30, 2016 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Luoxin Aurovitas | ALBUTEROL SULFATE | albuterol sulfate | SOLUTION;INHALATION | 211888-002 | Apr 20, 2020 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Luoxin Aurovitas | ALBUTEROL SULFATE | albuterol sulfate | SOLUTION;INHALATION | 206224-001 | Oct 17, 2017 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
